PFM Health Sciences LP Has $43.51 Million Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

PFM Health Sciences LP grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 63.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 686,150 shares of the company’s stock after buying an additional 265,986 shares during the period. Acadia Healthcare makes up 2.5% of PFM Health Sciences LP’s portfolio, making the stock its 13th largest position. PFM Health Sciences LP’s holdings in Acadia Healthcare were worth $43,509,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. boosted its stake in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock worth $36,000 after purchasing an additional 248 shares during the period. GAMMA Investing LLC boosted its stake in Acadia Healthcare by 57.1% in the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock worth $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare in the 2nd quarter worth $59,000. Covestor Ltd boosted its stake in Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in Acadia Healthcare in the 3rd quarter worth $86,000.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of research analyst reports. Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 22nd. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research report on Monday, November 18th. KeyCorp started coverage on shares of Acadia Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $79.67.

Acadia Healthcare Stock Down 1.6 %

Shares of ACHC stock opened at $40.63 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm’s 50-day moving average is $51.17 and its 200-day moving average is $63.79. The stock has a market cap of $3.77 billion, a price-to-earnings ratio of 13.32, a PEG ratio of 1.83 and a beta of 1.33. Acadia Healthcare Company, Inc. has a 52-week low of $36.50 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period in the prior year, the firm earned $0.91 EPS. Acadia Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.